Mutational analysis of human P-glycoprotein.
Loo
T W
TW
Department of Medicine, University of Toronto, Ontario, Canada.
Clarke
D M
DM
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis* / Q000302:isolation & purification / Q000378:metabolism; D019943:Amino Acid Substitution; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase / Q000378:metabolism; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003001:Cloning, Molecular / Q000379:methods; D003078:Colchicine / Q000633:toxicity; D004252:DNA Mutational Analysis / Q000379:methods; D004926:Escherichia coli; D006801:Humans; D007202:Indicators and Reagents; D007700:Kinetics; D016297:Mutagenesis, Site-Directed; D010843:Pichia; D017354:Point Mutation; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism; D012441:Saccharomyces cerevisiae; D018411:Spodoptera; D014162:Transfection / Q000379:methods; D014700:Verapamil / Q000633:toxicity; D014747:Vinblastine / Q000633:toxicity
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D007202:Indicators and Reagents; D011994:Recombinant Proteins; D014747:Vinblastine; D014700:Verapamil; D017301:Ca(2+) Mg(2+)-ATPase; D003078:Colchicine